![]() |
市場調查報告書
商品編碼
1882990
自動化內視鏡清洗消毒機 (AER) 市場規模、佔有率、成長及全球產業分析:按類型、應用和地區劃分的洞察與預測 (2024-2032)Automated Endoscope Reprocessors (AER) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032 |
||||||
隨著全球醫療系統日益重視更嚴格的感染控制、標準化的消毒流程以及微創診斷技術的廣泛應用,全球自動化內視鏡清洗消毒機 (AER) 市場持續穩定成長。根據本報告預測,2024 年全球 AER 市場規模預計將達到 6.977 億美元,2025 年將達到 7.256 億美元,到 2032 年將進一步增長至 10.064 億美元,預測期內複合年增長率 (CAGR) 為 4.8%。 2024 年,北美地區憑藉先進的醫療基礎設施和較高的內視鏡檢查頻率,以 49% 的市佔率引領全球市場。
自動內視鏡清洗消毒機 (AER) 是清潔和消毒可重複使用內視鏡的必備設備,它透過自動化的高效消毒循環來實現這一目標。這些系統確保了一致的滅菌效果,最大限度地減少了人為錯誤,並幫助醫療機構保護患者免受醫療相關感染 (HAI) 的侵害。隨著手術量的增加和對感染預防的日益重視,AER 的應用已成為醫院安全規程的基本要素。
市場驅動因素
推動市場成長的最大驅動因素之一是內視鏡檢查數量的增加,而這又受到全球胃腸道、呼吸系統和腫瘤疾病發病率上升的驅動。根據美國國家生物技術資訊中心 (NCBI) 於 2024 年 5 月發布的數據,美國每年將進行超過 1,770 萬例胃腸道內視鏡檢查,凸顯了高效再處理設備的巨大需求。全球人口老化也是推動需求成長的因素之一,因為老年人罹患慢性病的比例較高,需要定期進行診斷檢測。檢查量的激增直接加速了醫院和專科診所對先進自動內視鏡清洗消毒系統(AER)的需求。
市場限制因子
儘管成長因素強勁,但低收入國家熟練人員短缺構成了一項重大挑戰。內視鏡清洗消毒需要專門培訓,以確保符合感染控制指南。正如澳洲皇家全科醫師學院(RACGP)在2024年6月指出的那樣,醫療機構必須確保其員工接受過充分的培訓,這在許多資源匱乏的環境中是一項既困難又昂貴的要求。這種技能缺口迫使一些醫療中心依賴人工清洗消毒方法,限制了AER的廣泛應用。
市場機會
新興經濟體蘊藏著巨大的成長潛力。人們對醫院獲得性感染(HAI)的認識不斷提高、醫院基礎設施不斷擴建以及對外科和診斷服務的投資增加,都在推動AER的普及。例如,2025年4月,印度Yashoda醫院開設了機器人輔助神經外科和神經內視鏡手術卓越中心,凸顯了該地區微創手術的蓬勃發展。政府主導的現代化項目和不斷增長的私營部門投資進一步鞏固了對經濟高效、結構緊湊且專為小型醫療機構設計的AER系統的長期需求。
市場挑戰
AER系統廣泛應用的主要障礙之一是其高昂的初始投資。這些成本包括設備本身、專用安裝空間、水過濾系統、通風設備以及持續的消毒劑採購。小型診所和醫院往往預算不足,限制了普及。高昂的維護成本和設備維護要求也會推高營運成本,減緩成本敏感地區的市場擴張。
主要市場趨勢
技術進步正在推動AER市場的新趨勢。由於效率低且人為錯誤風險高,醫療機構正逐步淘汰人工清潔。這推動了對具備增強型數位化工作流程整合、即時數據記錄和追蹤系統的自動內視鏡清洗系統 (AER) 的需求。例如,Getinge 於 2022 年推出的改良型 ED-Flow AER 就具有增強的數位化連線功能。美國疾病管制與預防中心 (CDC)、美國食品藥物管理局 (FDA) 和歐洲胃腸內視鏡學會 (ESGE) 的嚴格指南進一步鼓勵醫療機構採用先進的自動化系統,以確保合規性和可追溯性。
北美
北美市場將在 2024 年佔領先地位,達到 3.419 億美元。該地區內視鏡檢查率高,且感染控制要求嚴格,這推動了市場需求。在美國,僅胃腸內視鏡檢查就佔所有內視鏡檢查的 68% 以上。
歐洲
在嚴格的監管標準、不斷增長的醫療保健預算以及向標準化自動化消毒設備的轉變的推動下,歐洲將在2024年位居第二。
亞太地區
由於醫院感染率上升和醫療設施快速擴張,亞太地區預計將實現最高的複合年增長率。在印度,10-20%的患者會發生醫院感染,迫使醫院改善其消毒系統。
拉丁美洲、中東和非洲
在這些地區,由於感染控制意識的提高和醫療保健領域的大量投資,自動化消毒設備(AER)的採用率正在逐步提高。
The global automated endoscope reprocessors (AER) market continues to grow steadily as healthcare systems worldwide prioritize stricter infection control, standardized reprocessing procedures, and increased adoption of minimally invasive diagnostics. According to the report, the global AER market was valued at USD 697.7 million in 2024, is projected to reach USD 725.6 million in 2025, and is expected to climb to USD 1,006.4 million by 2032, reflecting a CAGR of 4.8% during the forecast period. In 2024, North America dominated the global market with a 49% share, supported by advanced healthcare infrastructure and high volumes of endoscopic procedures.
Automated endoscope reprocessors are essential devices used to clean and disinfect reusable endoscopes through automated high-level disinfection cycles. These systems ensure consistent sterilization outcomes, minimize human error, and help healthcare facilities protect patients from healthcare-associated infections (HAIs). With rising procedure volume and growing emphasis on infection prevention, AER adoption has become a fundamental part of hospital safety protocols.
Market Drivers
One of the strongest contributors to market growth is the increasing number of endoscopic procedures, driven by rising global incidence of gastrointestinal, pulmonary, and oncological disorders. According to NCBI data published in May 2024, over 17.7 million GI endoscopic procedures are performed annually in the U.S., highlighting the volume of devices that require efficient reprocessing. An aging global population also elevates demand, as older adults experience higher rates of chronic diseases requiring regular diagnostic examinations. This surge in procedures directly accelerates the need for advanced AER systems in hospitals and specialty clinics.
Market Restraints
Despite strong growth factors, a major challenge is the limited availability of skilled staff in low-income countries. Endoscope reprocessing requires specialized training to ensure compliance with infection control guidelines. As highlighted by the Royal Australian College of General Practitioners (RACGP) in June 2024, facilities must ensure staff are adequately trained-a requirement that is difficult and costly for many under-resourced settings. This skill gap leads some healthcare centers to rely on manual reprocessing methods, limiting AER penetration.
Market Opportunities
Emerging economies present substantial growth prospects. Rising awareness of HAIs, expanding hospital infrastructure, and increased investments in surgical and diagnostic services are boosting adoption. For example, in April 2025, Yashoda Hospitals in India launched a Center of Excellence for Robotic Neurosurgery and Neuro Endoscopy, highlighting the region's expansion in minimally invasive procedures. Government-funded modernization programs and increasing private sector investments further strengthen the long-term demand for cost-effective, compact AER systems designed for smaller facilities.
Market Challenges
One of the key barriers to broader adoption is the high initial investment associated with AER systems. Costs include the equipment itself, dedicated installation space, water filtration systems, ventilation, and ongoing purchases of disinfectants. Smaller clinics and hospitals often lack sufficient budgets, restricting their adoption. Higher maintenance costs and device servicing needs also elevate operational expenses, slowing market expansion in cost-sensitive regions.
Key Market Trends
Technological advancements are shaping new trends in the AER market. Healthcare providers are transitioning away from manual cleaning due to its inefficiency and higher risk of human error. AERs equipped with enhanced digital workflow integration, real-time data logging, and tracking systems are in growing demand. For example, Getinge's updated ED-Flow AER introduced in 2022 incorporated improved digital connectivity features. Strict guidelines from CDC, FDA, and ESGE are further encouraging facilities to adopt advanced, automated systems to ensure compliance and traceability.
North America
North America led the market in 2024 with USD 341.9 million. High endoscopy procedure rates and advanced infection control requirements drive regional demand. GI procedures alone account for over 68% of all endoscopic procedures in the U.S.
Europe
Europe ranked second in 2024, supported by strong regulatory standards, increasing healthcare budgets, and a shift toward standardized automated reprocessing.
Asia Pacific
Asia Pacific is expected to record the highest CAGR, fueled by rising nosocomial infection rates and rapid healthcare facility expansion. In India, 10-20% of patients experience hospital-acquired infections, pushing hospitals toward improved disinfection systems.
Latin America & Middle East & Africa
These regions are gradually adopting AERs, supported by increasing awareness of infection control and targeted healthcare investments.
Conclusion
Growing from USD 697.7 million in 2024 to USD 725.6 million in 2025, and projected to reach USD 1,006.4 million by 2032, the global automated endoscope reprocessors market is on a steady upward trajectory. Rising endoscopy volumes, strict infection control mandates, and expanding healthcare capacity in emerging economies will continue shaping market growth in the coming years.
Segmentation By Type
By Loading Type
By Portability
By Type of Endoscope Reprocessed
By End-user
By Region